Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes.
about
Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic RetinopathyThe mouse retina as an angiogenesis model.Subclinical capillary changes in non-proliferative diabetic retinopathy.Downregulation of Lysyl Oxidase Protects Retinal Endothelial Cells From High Glucose-Induced ApoptosisRodent Hyperglycemia-Induced Inner Retinal Deficits are Mirrored in Human DiabetesInhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway.Influence of retinopathy on the achromatic and chromatic vision of patients with type 2 diabetesMultifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetesHigh prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with proliferative diabetic retinopathy.Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy.Early neural and vascular changes in the adolescent type 1 and type 2 diabetic retina.Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes?Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy.Cellular response to tissue hypoxia and its involvement in disease progression.Impact of long-term measures of glucose and blood pressure on the retinal microvasculature.A multifocal electroretinogram model predicting the development of diabetic retinopathy.Advances in retinal imaging for diabetic retinopathy and diabetic macular edema.Treatment of neovascular age-related macular degeneration in patients with diabetes.Adolescents with Type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation.Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trialDigital ocular fundus imaging: a review.Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.Nerve growth factor in diabetic retinopathy: beyond neurons.Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice.Therapeutic efficacy of melatonin in reducing retinal damage in an experimental model of early type 2 diabetes in rats.Microangiopathy and visual deficits characterize the retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome.Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases.Deletion of p75 prevents vaso-obliteration and retinal neovascularization via activation of Trk- A receptor in ischemic retinopathy model
P2860
Q29248994-E2CE746C-E508-4C8B-9C07-4A6DEBE721B3Q30495106-7948CDFC-B004-451C-985E-6500DB48460FQ30514002-2015A512-1C3B-4D8B-A315-A9A50E333337Q33727611-622DF500-1F05-4672-B733-3EACA5AA6C53Q33782405-83D05BF8-F20D-4679-825B-72C3E392A328Q33930328-3EBFC668-459B-402B-A12E-4178558BC920Q34538639-46FB706B-E906-44CC-9C3A-0CABC55E03DDQ34645677-79EAFEA0-5365-4D7E-A63E-269E532945ABQ35231784-46CB59CE-2FAE-46EA-92C3-6585E97C52E2Q35234189-64CE729F-3B7F-4E90-A269-862D3386DF06Q35605793-100BA6BD-CEB6-4F59-92BF-BF75BB93C1B5Q35761602-3FD4CF6F-4755-4A11-A2DB-7A413AF63B65Q36145936-C6856017-A0DC-47CF-8FE2-25537E016D5EQ36268487-CFFF3416-536B-40DA-B777-913729D0573DQ36441820-9686CC70-E03A-4AFB-BC04-C54498AF4828Q36584270-5B4327B9-A395-4395-9CA2-CA477218BF42Q36766212-87A653FC-A7EF-4CDE-9BA6-C8A6485B7BCFQ37221478-47F45D2A-5412-4092-BE2B-00B4703AB214Q37297322-A1A14B2C-656A-4AFD-BB13-35635770D576Q37695091-6A7B3823-0BE7-4BBD-B872-89A9B1F72B27Q37939563-696FBE8E-6A19-4604-A55A-CF82D8680F12Q38227391-EBBB7072-E694-4E42-9EDB-53D4A4F945A2Q38230380-701E003B-929A-4F21-9B80-603E17C54607Q43160577-591C9457-9EEF-4919-B22C-93525088DE1FQ44418091-C45DBEFD-CA16-4B2B-91CE-D69191E36194Q51351946-63347044-2E51-45C3-8705-6168430C3E14Q52901126-13869919-16AF-4646-937D-6F243AAED5A6Q53191840-9621145C-05DC-4699-B3D1-69DF86DCFA03Q58730618-39D49C99-4BFC-4FE8-B64B-58F0ED21D245
P2860
Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nonproliferative retinopathy i ...... haracterization of phenotypes.
@ast
Nonproliferative retinopathy i ...... haracterization of phenotypes.
@en
type
label
Nonproliferative retinopathy i ...... haracterization of phenotypes.
@ast
Nonproliferative retinopathy i ...... haracterization of phenotypes.
@en
prefLabel
Nonproliferative retinopathy i ...... haracterization of phenotypes.
@ast
Nonproliferative retinopathy i ...... haracterization of phenotypes.
@en
P1476
Nonproliferative retinopathy i ...... haracterization of phenotypes.
@en
P2093
José Cunha-Vaz
Rui Bernardes
P304
P356
10.1016/J.PRETEYERES.2004.07.004
P577
2004-12-16T00:00:00Z